Difficulty: Medium
Average Score: 85%
Practice
Which of the following opioid analgesics can produce an increase in the pulmonary arterial pressure and myocardial work?
Correct answer
A
Rationale
In the context of advanced pharmacology across the lifespan, understanding the cardiovascular effects of opioid analgesics is crucial for safe prescribing and patient management. In this scenario, the correct answer is A) Morphine.
Morphine, a potent opioid analgesic, can lead to an increase in pulmonary arterial pressure and myocardial work due to its vasodilatory effects. By causing vasodilation, morphine can decrease systemic vascular resistance, which in turn increases pulmonary arterial pressure and myocardial workload.
Now, let's discuss why the other options are incorrect:
B) Pentazocine: Pentazocine is a mixed opioid agonist-antagonist, and its cardiovascular effects are not as pronounced as those of morphine.
C) Meperidine: Meperidine is known to have a metabolite (normeperidine) that can accumulate in the body and lead to central nervous system excitation and seizures, but it is not primarily associated with significant cardiovascular effects.
D) Methadone: While methadone can prolong the QT interval and lead to cardiac arrhythmias, it is not typically known for causing a significant increase in pulmonary arterial pressure and myocardial work like morphine.
Educationally, this question highlights the importance of understanding the specific cardiovascular effects of different opioid analgesics to make informed clinical decisions and provide optimal patient care, especially in individuals with underlying cardiovascular conditions or at risk for cardiovascular complications. It underscores the need for healthcare providers to be vigilant in monitoring and managing potential adverse effects of opioids on the cardiovascular system.
Morphine, a potent opioid analgesic, can lead to an increase in pulmonary arterial pressure and myocardial work due to its vasodilatory effects. By causing vasodilation, morphine can decrease systemic vascular resistance, which in turn increases pulmonary arterial pressure and myocardial workload.
Now, let's discuss why the other options are incorrect:
B) Pentazocine: Pentazocine is a mixed opioid agonist-antagonist, and its cardiovascular effects are not as pronounced as those of morphine.
C) Meperidine: Meperidine is known to have a metabolite (normeperidine) that can accumulate in the body and lead to central nervous system excitation and seizures, but it is not primarily associated with significant cardiovascular effects.
D) Methadone: While methadone can prolong the QT interval and lead to cardiac arrhythmias, it is not typically known for causing a significant increase in pulmonary arterial pressure and myocardial work like morphine.
Educationally, this question highlights the importance of understanding the specific cardiovascular effects of different opioid analgesics to make informed clinical decisions and provide optimal patient care, especially in individuals with underlying cardiovascular conditions or at risk for cardiovascular complications. It underscores the need for healthcare providers to be vigilant in monitoring and managing potential adverse effects of opioids on the cardiovascular system.